This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Burn of Larynx and Trachea — Upper Airway Inhalation Injury후두 및 기관의 화상 (후두·기관 흡입 화상)

Contents and key points
ItemDetails
A. Classification codesICD-10: T27.0 (burn of larynx and trachea) | Special Copayment Reduction: V250 (special copayment reduction for severe burns, category 4: burns of the respiratory and alimentary tracts; 5% copayment for 1 year from the registration date)
B. SynonymsLaryngeal inhalation injury, tracheal burn, upper airway inhalation injury, Inhalation injury supraglottic, Laryngotracheal burn
C. Adult onsetOccurs in adults from enclosed-space fires, explosions and inhalation of chemical gases. The risk of airway obstruction is high, and immediate airway management determines survival.
1. HistoryFollowing the 1942 Cocoanut Grove fire, research on the pathophysiology of inhalation injury and treatment systems developed rapidly.
2. CausesInhalation of hot gases, steam or smoke; enclosed-space fires; inhalation of CO, HCN and irritant chemical gases
3. GeneticsNo direct genetic cause; individual differences exist in airway reactivity and intensity of the inflammatory response
4. General epidemiologyInhalation injury accompanies about 20~33% of severe burns; an independent prognostic factor that increases mortality by more than 40%
5. PathophysiologyHeat-induced upper airway mucosal edema, CO·HCN toxicity, acute airway inflammatory response due to chemical irritation
6. SymptomsHoarse voice, stridor, dyspnea, cough, carbonaceous sputum, headache·confusion (CO poisoning)
7. SignsNasal soot, singed nasal hair, pharyngeal erythema·blisters·eschar, wheezing, tachypnea, hypoxemia
8. ScreeningArterial blood gas analysis, COHb measurement, laryngoscopy·bronchoscopy, chest X-ray, pulse oximetry
9. DiagnosisFiberoptic bronchoscopy (gold standard), ABGA, COHb, chest CT, laryngoscopy to grade airway injury
10. TreatmentEarly endotracheal intubation, high-concentration O2, nebulized heparin/NAC for aspiration injury, mechanical ventilation, 100% O2 for CO poisoning
11. PrognosisInhalation injury significantly increases burn mortality, and pulmonary complications and airway stenosis may remain as long-term sequelae
12. PreventionWearing a positive-pressure breathing apparatus when working in enclosed spaces, installing fire detectors·sprinklers, ventilation systems for chemicals
13. ReferencesEnkhbaatar P & Traber DL "Pathophysiology of acute lung injury in combined burn and smoke inhalation injury" Clin Sci 2004 … and 9 other papers

1. History

Systematic recognition of inhalation injury advanced dramatically following the Cocoanut Grove nightclub fire in Boston, USA, in 1942. This disaster claimed 492 victims, and it was observed that many victims died from inhalation injury alone, without skin burns. Cope and Moore (1943), through clinical observation of the victims of this fire, were the first to systematically describe inhalation injury as an independent cause of death.

In the 1960s~70s, the three main mechanisms of inhalation injury were distinguished and defined: ① heat-induced upper airway injury, ② carbon monoxide (CO) toxicity, and ③ lower airway and lung injury from chemical irritants. Zawacki et al. (1977) published a system for the diagnosis and prognostic prediction of inhalation injury. In the 1980s, as hydrogen cyanide (HCN) toxicity was identified as an important toxic component of fire smoke, the importance of HCN antidote treatment (hydroxocobalamin) was emphasized.

Since the 1990s, bronchoscopy has become the standard for diagnosing inhalation injury, and injury grading based on bronchoscopic findings (Mlcak et al., 2007) is used for treatment planning and prognostic prediction. In Korea, the V250 special copayment reduction system provides systematic insurance support for patients with airway burns.


2. Causes

Burn of the larynx and trachea (T27.0) occurs when hot gases, steam, smoke, chemicals and the like are inhaled. Enclosed-space fire is the most common cause, with hot, toxic smoke inhaled in building fires, vehicle fires, tunnel fires and so on. Smoke contains various toxic substances such as carbon monoxide (CO), hydrogen cyanide (HCN), acrolein and hydrogen chloride. Steam and hot gases are mostly cooled in the upper airway and rarely reach the lower airways, but they cause direct thermal injury to the larynx and supraglottic region. Chemical gases such as ammonia, chlorine, formaldehyde and sulfur dioxide are inhaled in industrial accidents and cause chemical injury of the airway.


3. Genetics

Inhalation injury is trauma caused by environmental factors and has no direct genetic cause. However, there are genetic individual differences in the severity of lung injury and the speed of recovery after inhalation injury. Polymorphisms of the ADRB2 (beta-2 adrenergic receptor) gene, which determines bronchial hyperreactivity, may affect the bronchospastic response after inhalation injury. Polymorphisms of IL-6, TNF-α, ACE and others have been reported as ARDS susceptibility genes related to the development of acute lung injury (ALI) and ARDS. Polymorphisms of antioxidant enzyme (SOD2, GPX1) genes may affect the degree of cell damage from oxidative stress after smoke inhalation.


4. General epidemiology

Inhalation injury is reported to accompany about 20~33% of patients hospitalized for severe burns. In data from the US National Burn Repository, mortality of burn patients with inhalation injury is about 40% or more higher than that of patients without inhalation injury. Inhalation injury may also occur without burns, and CO poisoning is reported to account for more than 50% of fire deaths. According to Korean National Fire Agency data, a considerable proportion of deaths from indoor building fires are due to CO poisoning and smoke inhalation injury. Occupational occurrence (firefighters, mine workers, chemical handlers) is also an important epidemiological factor.


5. Pathophysiology

The pathophysiology of burns of the larynx and trachea is explained by three main mechanisms. The first is direct thermal injury. Hot gases and steam are cooled mainly in the larynx and supraglottic region, causing thermal injury to the upper airway mucosa. This causes mucosal edema, blistering and necrosis, and rapid subglottic edema in particular causes airway obstruction. The second is CO toxicity. CO has 200~250 times greater affinity for hemoglobin than oxygen, forming carboxyhemoglobin (COHb) and causing tissue hypoxia. It also inhibits mitochondrial cytochrome oxidase within cells, blocking cellular respiration. The third is HCN toxicity. HCN is produced when furniture, plastics and synthetic fibers burn, and it inhibits the mitochondrial electron transport chain at the cellular level, causing severe intracellular hypoxia.

In airway injury from chemical irritants, release of reactive oxygen species (ROS) and proteases worsens mucosal epithelial injury. Fluid and fibrin accumulate on the damaged mucosa, forming pseudomembranes and fibrin casts, which cause airway obstruction and ventilation-perfusion mismatch (V/Q mismatch).


6. Symptoms

Acute symptoms of burns of the larynx and trachea worsen progressively within hours of injury. Hoarseness and stridor are important signs of glottic and laryngeal mucosal edema and suggest impending airway obstruction. Dyspnea and tachypnea reflect increased airway resistance and hypoxemia. Carbonaceous sputum is direct evidence of smoke inhalation. Symptoms of CO poisoning include headache, dizziness, vomiting and clouded consciousness, and in severe cases seizures and coma occur. HCN poisoning presents with metabolic acidosis (lactic acidosis) and circulatory collapse. Cough, sore throat and dysphagia may accompany it.


7. Signs

On physical examination, external signs of inhalation injury include soot in the nasal cavity, singed nasal vibrissae, facial burns and loss of eyebrows·eyelashes. Erythema, blisters, eschar and edema of the oral·pharyngeal mucosa are visually confirmed. Stridor is heard over the neck, and wheezes and crackles may be heard on auscultation of breath sounds. Pulse oximetry shows decreased oxygen saturation, or in CO poisoning actual oxygen delivery is reduced despite a normal SpO2 (COHb cannot be measured by pulse oximetry). Increased heart rate, blood pressure fluctuations and changes in mental status reflect systemic toxicity.


8. Screening

Arterial blood gas analysis (ABGA) is the key test for assessing oxygenation, carbon dioxide elimination and acid-base status. Carboxyhemoglobin (COHb) measurement is performed by CO-oximetry on venous or arterial blood and is essential for diagnosing CO poisoning. COHb >25% indicates severe CO poisoning, and >50% is life-threatening. Lactate measurement reflects HCN toxicity and tissue hypoxia. Even if the initial chest X-ray is normal, pulmonary edema or aspiration pneumonia may appear hours later, so follow-up imaging is important. Laryngoscopy allows direct visualization of the condition of the glottic and supraglottic mucosa.


9. Diagnosis

Fiberoptic bronchoscopy is the standard test for diagnosing inhalation injury. Mucosal erythema, blisters, eschar, carbon deposition and fibrin casts in the airway are directly visualized. Airway injury is classified as Grade 0~4 according to the Mlcak classification to predict prognosis. Bronchoalveolar lavage (BAL) identifies cellular components and carbon particles. Chest CT is useful for early assessment of pulmonary parenchymal injury and monitoring of complications (pneumonia, ARDS). Clinical inhalation injury can be diagnosed when three or more laryngoscopic findings and clinical symptoms (stridor, hoarseness, carbonaceous sputum) are present.


10. Treatment

Airway management

The most important initial treatment in inhalation injury is securing the airway. If stridor, hoarseness or progressive edema is present, early endotracheal intubation should be performed. Delay can worsen the edema and make intubation impossible. A surgical airway (cricothyrotomy, tracheostomy) is sometimes needed.

Treatment of CO and HCN toxicity

For CO poisoning, high-concentration 100% oxygen (non-rebreathing mask) is given immediately, shortening the half-life of COHb from 90 minutes to about 30 minutes. For severe CO poisoning (COHb >25%, neurological symptoms, cardiac complications), hyperbaric oxygen therapy is considered. If HCN toxicity is suspected (metabolic lactic acidosis, circulatory collapse), intravenous hydroxocobalamin (Cyanokit) 5g is the standard treatment.

Treatment of aspiration airway injury

After intubation, mechanical ventilation is performed with a lung-protective strategy (lung-protective ventilation: tidal volume 6mL/kg IBW, titrated PEEP). There is evidence that the heparin/NAC protocol of alternating nebulization of nebulized heparin (5,000~10,000 units, every 4 hours) and N-acetylcysteine (NAC, 20% solution 3mL, every 4 hours) suppresses fibrin cast formation and improves lung injury indices. Airway fibrin casts are removed by airway clearance (percussion therapy, position changes) and periodic bronchoscopic lavage. When ARDS develops, rescue therapies such as prone positioning, PEEP optimization and high-frequency oscillatory ventilation (HFOV) are considered.


11. Prognosis

Inhalation injury, including burns of the larynx and trachea, independently and significantly increases burn mortality. When inhalation injury is present, 17 points are added to the Baux score (revised Baux score) to predict mortality. Mortality with inhalation injury alone (no skin burns) is about 5~8%, but it rises greatly when combined with extensive skin burns. In the long term, complications such as tracheal stenosis, bronchial hyperresponsiveness, reduced lung function and recurrent pneumonia may develop. Tracheal stenosis occurs in 10~20% after prolonged intubation or tracheostomy, and tracheoplasty may be required.


12. Prevention

Wearing a positive-pressure self-contained breathing apparatus (SCBA) when working in enclosed spaces is the most effective preventive measure. Buildings should be fitted with smoke detectors, sprinkler systems and CO detectors, which should be maintained regularly. Facilities handling chemicals should install local exhaust ventilation systems and operate gas leak detectors. Firefighters and hazardous material handlers need regular training on the signs of inhalation injury and first aid (in CO poisoning, move immediately to fresh air and give 100% oxygen).


13. References

  1. Enkhbaatar P, Traber DL. Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond). 2004;107(2):137-143. DOI: 10.1042/CS20040135. PMID: 15132443.

  2. Mlcak RP, Suman OE, Herndon DN. Respiratory management of inhalation injury. Burns. 2007;33(1):2-13. DOI: 10.1016/j.burns.2006.09.012. PMID: 17222512.

  3. Cancio LC. Airway management and smoke inhalation injury in the burn patient. Clin Plast Surg. 2009;36(4):555-567. DOI: 10.1016/j.cps.2009.05.013. PMID: 19793550.

  4. Rehberg S, Maybauer MO, Enkhbaatar P, Maybauer DM, Yamamoto Y, Traber DL. Pathophysiology, management and treatment of smoke inhalation injury. Expert Rev Respir Med. 2009;3(3):283-297. DOI: 10.1586/ers.09.17. PMID: 20477289.

  5. Sheridan RL, Keaney T, Kinley E, et al. Short-term outcomes of severely burned children with CO poisoning. Pediatr Crit Care Med. 2003;4(4):432-434. DOI: 10.1097/01.PCC.0000082205.73261.22. PMID: 14525639.

  6. Phelps MK, Olson LM, Patel MAV, Thompson MJ, Murphy CV. Nebulized heparin for adult patients with smoke inhalation injury: a review of the literature. J Pharm Pract. 2020;33(6):854-861. DOI: 10.1177/8755122520925774. PMID: 32428980.

  7. Woodson LC. Diagnosis and grading of inhalation injury. J Burn Care Res. 2009;30(1):143-145. DOI: 10.1097/BCR.0b013e3181921ead. PMID: 19060730.

  8. Dries DJ. Management of burn injuries — recent developments in resuscitation, infection control and outcomes research. Scand J Trauma Resusc Emerg Med. 2009;17:14. DOI: 10.1186/1757-7241-17-14. PMID: 19291302.

  9. Hamahata A, Enkhbaatar P, Kraft ER, et al. Effect of nebulized heparin on pulmonary function after severe smoke inhalation injury in sheep. Burns. 2009;35(2):315-320. DOI: 10.1016/j.burns.2008.07.009. PMID: 18947935.

  10. Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. Current treatment of severely burned patients. Ann Surg. 1996;223(1):14-25. DOI: 10.1097/00000658-199601000-00004. PMID: 8554414.